Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
VEON
VEON
$3.95B
| $419K | ﹤0.01% |
7,043
+1
| +0% | +$63 |
|
4052
Addus HomeCare
ADUS
$2.23B
| $418K | ﹤0.01% |
7,297
+5,356
| +276% | +$293K |
|
4053
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$161M
| $418K | ﹤0.01% |
4,600
+2,800
| +156% | +$311K |
|
|
ADAP
4054
DELISTED
Adaptimmune Therapeutics
ADAP
| $417K | ﹤0.01% |
35,111
-840
| -2% | -$10.5K |
|
4055
iPath Select MLP ETN
ATMP
$621M
| $417K | ﹤0.01% |
20,575
+20,000
| +3,478% | +$398K |
|
4056
PUT
Crane NXT
CXT
$3.07B
| $417K | ﹤0.01% |
+14,971
| New | +$451K |
|
4057
PUT
ProShares UltraShort S&P500
SDS
$390M
| $417K | ﹤0.01% |
436
+228
| +110% | +$222K |
|
4058
OraSure Technologies
OSUR
$279M
| $416K | ﹤0.01% |
25,264
-12,750
| -34% | -$215K |
|
4059
PUT
Buckle
BKE
$2.37B
| $414K | ﹤0.01% |
15,400
+3,000
| +24% | +$74.3K |
|
4060
PUT
EQT Corp
EQT
$32.3B
| $414K | ﹤0.01% |
13,778
-37,842
| -73% | -$1.06M |
|
4061
CALL
Applied Optoelectronics
AAOI
$11.5B
| $413K | ﹤0.01% |
9,200
+3,400
| +59% | +$121K |
|
4062
Astronics
ATRO
$3.84B
| $412K | ﹤0.01% |
15,804
-7,097
| -31% | -$188K |
|
4063
CytomX Therapeutics
CTMX
$754M
| $411K | ﹤0.01% |
17,989
+1,957
| +12% | +$50K |
|
|
MDR
4064
PUT
DELISTED
McDermott International
MDR
| $410K | ﹤0.01% |
20,879
+19,612
| +1,548% | +$398K |
|
|
ITCI
4065
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $408K | ﹤0.01% |
23,100
-21,600
| -48% | -$439K |
|
4066
Cadiz
CDZI
$291M
| $407K | ﹤0.01% |
31,092
+26,622
| +596% | +$346K |
|
4067
PUT
Ecolab
ECL
$79.9B
| $407K | ﹤0.01% |
2,900
-26,300
| -90% | -$3.79M |
|
4068
CALL
Interactive Brokers
IBKR
$39.8B
| $406K | ﹤0.01% |
25,200
-38,400
| -60% | -$695K |
|
|
TRTN
4069
DELISTED
Triton International Limited
TRTN
| $406K | ﹤0.01% |
13,222
-6,807
| -34% | -$225K |
|
4070
PUT
TE Connectivity
TEL
$62.6B
| $405K | ﹤0.01% |
4,500
-5,100
| -53% | -$488K |
|
4071
CALL
Alexandria Real Estate Equities
ARE
$8.56B
| $404K | ﹤0.01% |
+3,200
| New | +$400K |
|
4072
Workiva
WK
$3.54B
| $404K | ﹤0.01% |
16,511
-44,402
| -73% | -$1.12M |
|
4073
Geospace Technologies
GEOS
$75.7M
| $403K | ﹤0.01% |
28,650
+24,571
| +602% | +$285K |
|
|
AEGN
4074
DELISTED
Aegion Corp
AEGN
| $403K | ﹤0.01% |
15,677
-9,101
| -37% | -$226K |
|
|
YELL
4075
DELISTED
Yellow Corporation Common Stock
YELL
| $402K | ﹤0.01% |
40,061
-58,941
| -60% | -$583K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.